إعلان
إعلان

ATRC

ATRC logo

AtriCure, Inc.

41.76
USD
برعاية
+0.32
+0.78%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

41.77

0.00
0.00%

تقارير أرباح ATRC

النسبة الإيجابية المفاجئة

ATRC تفوق 30 من 40 آخر التقديرات.

75%

التقرير التالي

بيانات التقرير القادم
١٠ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$142.05M
/
-$0.09
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.80%
/
+800.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+14.30%
/
+12.50%

AtriCure, Inc. earnings per share and revenue

On ٢٩ أكتوبر ٢٠٢٥, ATRC reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 91.46% surprise. Revenue reached 134.27 مليون, compared to an expected 133.88 مليون, with a 0.29% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of -0.09 USD, with revenue projected to reach 142.05 مليون USD, implying an زيادة of 800.00% EPS, and زيادة of 5.80% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, AtriCure, Inc. reported EPS of -$0.01, beating estimates by 91.46%, and revenue of $134.27M, 0.29% above expectations.
The stock price moved down -3.81%, changed from $35.44 before the earnings release to $34.09 the day after.
The next earning report is scheduled for ١٠ فبراير ٢٠٢٦.
Based on 11 المحللين, AtriCure, Inc. is expected to report EPS of -$0.09 and revenue of $142.05M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان